𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of doxifluridine in advanced squamous cell carcinoma of the head and neck

✍ Scribed by Abele, Reto; Kaplan, Eli; Grossenbacher, Rudolf; Schmid, Hans J.; Cavalli, Franco

Book ID
123121302
Publisher
Elsevier Science
Year
1984
Weight
305 KB
Volume
20
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of mitoxantrone in advanc
Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck
✍ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap

A phase II study of mitoxantrone in adva
A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck
✍ H. Wheeler; R. L. Woods; J. Page; J. Levi πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 186 KB

Twenty patients with advanced squamous cell carcinomas (SCC) of the head and neck were entered into a phase II study of mitoxantrone at a dosage of either 12 mg/m2 or 14 mg/m2 given at 3 weekly intervals. None of the patients had received prior chemotherapy. One patient had a partial remission. Two